Dow Up1.22% Nasdaq Up2.00%

Champions Oncology, Inc. (CSBR)

3.57 Down 0.18(4.84%) 3:17PM EDT
ProfileGet Profile for:
Champions Oncology, Inc.
One University Plaza
Suite 307
Hackensack, NJ 07601
United States - Map
Phone: 201-808-8400

Index Membership:N/A
Full Time Employees:71

Business Summary 

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assists physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and gene sequencing that analyzes the genetic makeup of patientÂ’s tumor for the purpose of identifying useful drugs. In addition, the company offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that uses vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. Further, it provides a bank of tumors that are acquired, collected, processed, validated, and stored for the use in TOS. The company markets its products through Internet, word of mouth, and a network of sales force. It serves patients, physicians, and drug development companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Champions Oncology, Inc.

Key Executives 
Dr. David Sidransky M.D., Ph.D., 56
Founder, Chairman and Scientific Advisor
Mr. Joel Ackerman , 50
Chief Exec. Officer, Sec. and Director
Dr. Ronnie Morris M.D., 49
Pres and Director
Mr. David Barry Miller , 47
VP of Fin.
Mr. Mark Weinstein ,
Chief Information Officer
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders